Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC - PubMed (original) (raw)
Review
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
G B Frisoni et al. J Neurol Neurosurg Psychiatry. 2003 Oct.
Abstract
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The often equivocal clinical pictures, the prognostic uncertainty of the earliest stages of mild cognitive impairment, and the subtle brain changes mean that neuroimaging techniques are of potentially great incremental diagnostic value. A number of methods, ranging from very simple subjective visual ratings to highly sophisticated computerised tools, have been developed, which allow rating of structural and functional brain changes. The choice of the method is not obvious, and current guidelines provide no indications on which tools should be preferred. In this paper, we give indications for tools with demonstrated accuracy for detecting regional atrophy, cerebrovascular disease, and regional brain function, and discuss these according to increasing technological complexity, ranging from those with high feasibility that can be used at the patient's bedside to highly technological ones that require trained personnel and specific hardware and software.
Similar articles
- Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
Scheltens P, Korf ES. Scheltens P, et al. Curr Opin Neurol. 2000 Aug;13(4):391-6. doi: 10.1097/00019052-200008000-00005. Curr Opin Neurol. 2000. PMID: 10970055 Review. - Neuroimaging in cerebrovascular disorders: measurement of cerebral physiology after stroke and assessment of stroke recovery.
Mountz JM, Liu HG, Deutsch G. Mountz JM, et al. Semin Nucl Med. 2003 Jan;33(1):56-76. doi: 10.1053/snuc.2003.127293. Semin Nucl Med. 2003. PMID: 12605357 Review. - Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B, Nation DA; Alzheimer’s Disease Neuroimaging Initiative. Yew B, et al. Brain. 2017 Jul 1;140(7):1987-2001. doi: 10.1093/brain/awx112. Brain. 2017. PMID: 28575149 Free PMC article. - Measurement of regional cerebral blood flow in humans with single-photon-emitting radioisotopes.
Lassen NA. Lassen NA. Res Publ Assoc Res Nerv Ment Dis. 1985;63:9-20. Res Publ Assoc Res Nerv Ment Dis. 1985. PMID: 3895334 Review. No abstract available. - Single photon emission computed tomography brain imaging.
Mullan BP, O'Connor MK, Hung JC. Mullan BP, et al. Neurosurg Clin N Am. 1996 Oct;7(4):617-51. Neurosurg Clin N Am. 1996. PMID: 8905776 Review.
Cited by
- APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits.
Wehling E, Lundervold AJ, Standnes B, Gjerstad L, Reinvang I. Wehling E, et al. Behav Brain Funct. 2007 Oct 31;3:57. doi: 10.1186/1744-9081-3-57. Behav Brain Funct. 2007. PMID: 17974013 Free PMC article. - Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial.
Traini E, Carotenuto A, Fasanaro AM, Amenta F. Traini E, et al. J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623. J Alzheimers Dis. 2020. PMID: 32508323 Free PMC article. Clinical Trial. - The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.
Prins ND, van der Flier WA, Knol DL, Fox NC, Brashear HR, Nye JS, Barkhof F, Scheltens P. Prins ND, et al. Alzheimers Res Ther. 2014 Jul 21;6(4):47. doi: 10.1186/alzrt275. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478019 Free PMC article. - Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
den Haan J, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH. den Haan J, et al. Alzheimers Dement (Amst). 2019 May 10;11:383-391. doi: 10.1016/j.dadm.2019.03.006. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31193094 Free PMC article. - The clinical use of structural MRI in Alzheimer disease.
Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. Frisoni GB, et al. Nat Rev Neurol. 2010 Feb;6(2):67-77. doi: 10.1038/nrneurol.2009.215. Nat Rev Neurol. 2010. PMID: 20139996 Free PMC article. Review.
References
- Neurology. 2001 Mar 13;56(5):643-9 - PubMed
- Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9 - PubMed
- Neuroreport. 2001 Mar 26;12(4):851-5 - PubMed
- Neurobiol Aging. 2001 Jul-Aug;22(4):529-39 - PubMed
- AJNR Am J Neuroradiol. 1996 May;17(5):913-23 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical